Demographic characteristics and medication use of study participants
| Variable | Value (n=34) |
|---|---|
| Gender | |
| Female | 14 (41.2%) |
| Male | 20 (58.8%) |
| Race | |
| White or Caucasian | 26 (76.5%) |
| Black or African-American | 3 (8.8%) |
| Hispanic | 5 (14.7%) |
| Age* (years) | 64.5±7.6 |
| Diabetes medication use† | 33 (97.1%) |
| Lipid-lowering medication use‡ | 28 (82.4%) |
| Blood pressure medication use§ | 24 (70.6%) |
*Values are mean ± SD.
†Medications included metformin, pioglitazone, glipizide, gliclazide, glyburide, glimepiride, sitagliptin, linagliptin, canagliflozin, saxagliptin, insulin, and insulin glargine.
‡Medications included simvastatin, atorvastatin, lovastatin, fenofibrate, omega-3-acid ethyl esters, and rosuvastatin.
§Medications included metoprolol, atenolol, nebivolol, carvedilol, lisinopril, valsartan, quinapril, ramipril, losartan, amlodipine, hydrochlorothiazide, and teralosin.